DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Néel A, Henry B, Barbarot S. et al.
Long-term effectiveness and safety of interleukin-1 receptor antagonist
(anakinra) in Schnitzler’s syndrome: a French multicenter study.
Autoimmun Rev 2014;
13: 1035-1041
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.